Quantification of Lipid and Peptide Content in Antigenic Peptide-loaded Liposome Formulations by Reversed-phase UPLC using UV Absorbance and Evaporative Light Scattering Detection.


Journal

Journal of pharmaceutical sciences
ISSN: 1520-6017
Titre abrégé: J Pharm Sci
Pays: United States
ID NLM: 2985195R

Informations de publication

Date de publication:
04 2022
Historique:
received: 10 11 2021
revised: 20 01 2022
accepted: 20 01 2022
pubmed: 2 2 2022
medline: 26 4 2022
entrez: 1 2 2022
Statut: ppublish

Résumé

Antigenic peptide-loaded cationic liposomes have shown promise as cancer vaccines. Quantification of both peptides and lipids is critical for quality control of such vaccines for clinical translation. In this work we describe a reversed phase ultra-performance liquid chromatography (RP-UPLC) method that separates lipids (DOTAP, DOPC and their degradation products) and two physicochemically different peptides within 12 min. Samples were prepared by dilution in a 1:1 (v/v) mixture of methanol and water. Peptide quantification was done via UV detection and lipids were quantified by an evaporative light scattering detector (ELSD), both coupled to the RP-UPLC system, with high precision (RSD < 3.5%). We showed that the presence of lipids and peptides did not mutually influence their quantification. Limit of detection (LOD) and limit of quantification (LOQ), as determined in the ICH guidelines, were 6 and 20 ng for DOTAP, 12 ng and 40 ng for DOPC, 3.0 ng and 8.0 ng for peptide A and 2.4 ng and 7.2 ng for the more hydrophobic peptide B. Finally, lipid degradation of DOTAP and DOPC was monitored in peptide loaded DOTAP:DOPC liposomes upon storage at 4 °C and 40 °C.

Identifiants

pubmed: 35101553
pii: S0022-3549(22)00030-2
doi: 10.1016/j.xphs.2022.01.021
pii:
doi:

Substances chimiques

Cations 0
Liposomes 0
Peptides 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1040-1049

Informations de copyright

Copyright © 2022 The Authors. Published by Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Conflict of Interest The authors declare to have no conflict of interest.

Auteurs

Jeroen Heuts (J)

Department of Immunology, Leiden University Medical Centre, P.O. Box 9600, 2300 RC, Leiden, the Netherlands; Division of BioTherapeutics, Leiden Academic Centre for Drug Research (LACDR), Leiden University, P.O. Box 9502, 2300 RA, Leiden, the Netherlands.

Celine van Haaren (C)

Division of BioTherapeutics, Leiden Academic Centre for Drug Research (LACDR), Leiden University, P.O. Box 9502, 2300 RA, Leiden, the Netherlands.

Stefan Romeijn (S)

Division of BioTherapeutics, Leiden Academic Centre for Drug Research (LACDR), Leiden University, P.O. Box 9502, 2300 RA, Leiden, the Netherlands.

Ferry Ossendorp (F)

Department of Immunology, Leiden University Medical Centre, P.O. Box 9600, 2300 RC, Leiden, the Netherlands.

Wim Jiskoot (W)

Division of BioTherapeutics, Leiden Academic Centre for Drug Research (LACDR), Leiden University, P.O. Box 9502, 2300 RA, Leiden, the Netherlands.

Koen van der Maaden (K)

Department of Immunology, Leiden University Medical Centre, P.O. Box 9600, 2300 RC, Leiden, the Netherlands. Electronic address: K.van_der_Maaden@lumc.nl.

Articles similaires

Fragaria Light Plant Leaves Osmosis Stress, Physiological
Animals Huntington Disease Mitochondria Neurons Mice
Humans Chromatography, High Pressure Liquid Acetaminophen COVID-19 SARS-CoV-2

Classifications MeSH